Pharmacodynamics

Correct Answer

B — Positive allosteric modulator

Rationale

Benzodiazepines bind to a site on the gamma-aminobutyric acid type A receptor that is distinct from the gamma-aminobutyric acid binding site and enhance the frequency of chloride channel opening in the presence of gamma-aminobutyric acid. They do not open the channel independently and do not mimic gamma-aminobutyric acid directly, which places them in the positive allosteric modulator category. Full agonists activate a receptor by binding the primary ligand site. Competitive antagonists block agonist access. Inverse agonists reduce constitutive receptor activity below baseline.

Correct Answer

D — Nuclear receptors

Rationale

Glucocorticoids are lipophilic molecules that cross the cell membrane and bind to intracellular nuclear receptors, which function as transcription factors to regulate gene expression. This places them in the nuclear receptor class. G protein-coupled receptors are membrane-bound and transduce signals through second messengers. Ligand-gated ion channels are transmembrane proteins that gate ion flow directly upon ligand binding. Receptor tyrosine kinases are membrane-spanning enzyme-linked receptors that respond to growth factors and hormones such as insulin.

Correct Answer

A — Partial agonist

Rationale

Buprenorphine is a partial agonist at the mu-opioid receptor: it binds and activates the receptor but produces a submaximal response even when all available receptors are occupied. This ceiling effect on receptor activation contributes to its safety profile compared with full agonists such as morphine and heroin. Full agonists produce the maximum system response at saturating concentrations. Inverse agonists suppress constitutive receptor activity below baseline. Competitive antagonists block agonist access without producing a response of their own.

Correct Answer

C — Competitive reversible antagonist

Rationale

Naloxone is a competitive reversible antagonist at the mu-opioid receptor. It competes with opioid agonists for the same binding site and can be displaced by increasing agonist concentration. Its reversible nature means that in severe opioid overdose, very high opioid concentrations can re-occupy receptors as naloxone is cleared, which is why repeat dosing or a naloxone infusion may be needed in serious poisoning. Partial agonists activate the receptor but produce a submaximal response. Irreversible antagonists form covalent or near-covalent bonds that cannot be overcome. Inverse agonists suppress constitutive receptor activity.

Correct Answer

B — Irreversible antagonist

Rationale

Phenoxybenzamine forms a covalent bond with alpha-adrenergic receptors, producing permanent receptor inactivation that cannot be overcome by increasing agonist concentration. This irreversible classification distinguishes it from prazosin and other alpha-1 blockers, which are competitive reversible antagonists that can be displaced by high catecholamine concentrations. Partial agonists activate receptors to a submaximal degree. Positive allosteric modulators enhance agonist-induced receptor activation from a distinct binding site.

Correct Answer

A — Ligand-gated ion channel

Rationale

The nicotinic acetylcholine receptor is a pentameric ligand-gated ion channel in which acetylcholine binding directly gates the opening of an ion pore permeable to sodium and potassium, producing ion flux within milliseconds. This places it in the ligand-gated ion channel class, the fastest-acting receptor family. G protein-coupled receptors transduce signals through second messenger cascades over seconds to minutes. Receptor tyrosine kinases respond to growth factors and signal through phosphorylation cascades over minutes to hours. Nuclear receptors are intracellular transcription factors activated by lipophilic ligands, with effects requiring hours to days.

Correct Answer

C — Drug A is 100-fold more potent in receptor binding than Drug B

Rationale

The equilibrium dissociation constant and affinity are inversely related: a lower equilibrium dissociation constant indicates higher affinity. Drug A at 1 nanomolar has 100-fold greater binding affinity than Drug B at 100 nanomolar, so Drug A achieves the same receptor occupancy at 100-fold lower concentrations. A higher equilibrium dissociation constant indicates lower affinity, so Drug B binds less tightly. At a drug concentration equal to the equilibrium dissociation constant, exactly 50% of receptors are occupied at equilibrium, not 100%. Affinity (equilibrium dissociation constant) determines binding potency, not the maximum effect; maximum effect depends on the drug's intrinsic efficacy, which is a separate property.

Correct Answer

A — Tiotropium dissociates from the muscarinic receptor much more slowly than ipratropium

Rationale

The duration of drug effect at a receptor is determined not just by plasma drug concentration but by receptor residence time — how long the drug remains bound. Tiotropium has a dramatically slower dissociation rate from the muscarinic M3 receptor compared with ipratropium, meaning the drug-receptor complex persists long after plasma concentrations fall. This prolonged receptor occupancy maintains bronchodilation for 24 hours with a single dose. A lower plasma half-life would shorten, not extend, the dosing interval. Both drugs act at muscarinic receptors with preference for M3. Lower receptor affinity would require higher concentrations to achieve the same effect, not longer duration.

Correct Answer

D — Platelets lack a nucleus and cannot synthesize new cyclooxygenase, so inhibited platelets remain inactive for their entire lifespan

Rationale

Aspirin acetylates platelet cyclooxygenase-1 covalently and permanently. Because platelets are anucleate cell fragments that cannot synthesize new proteins, they cannot replace the inactivated enzyme. The antiplatelet effect therefore lasts the full lifespan of those platelets — approximately 7 to 10 days — regardless of aspirin's rapid elimination from plasma. This is the defining clinical consequence of irreversible enzyme inhibition in a cell that cannot perform protein synthesis. New platelet production gradually restores normal platelet function as inhibited platelets are replaced.

Correct Answer

B — Reduced net opioid effect because buprenorphine displaces the full agonist and delivers less signal per occupied receptor

Rationale

When a partial agonist is present in an environment with a full agonist, it competes for receptor occupancy. Because buprenorphine has very high receptor affinity, it can displace full agonist opioids from mu-opioid receptors. However, each buprenorphine-receptor complex generates less downstream signal than a full agonist-receptor complex would. The net result is reduced total receptor-mediated signaling compared to the full agonist acting alone — the partial agonist behaves as a functional antagonist in this context. This is why buprenorphine can precipitate withdrawal in opioid-dependent patients and reduces the reinforcing effects of heroin use.

Correct Answer

C — An inverse agonist reduces constitutive receptor activity below the basal level, while a neutral antagonist does not alter baseline signaling

Rationale

Many receptors, particularly G protein-coupled receptors, exhibit constitutive activity — a low level of spontaneous signaling in the absence of any ligand. A neutral antagonist blocks access of agonists without affecting this baseline constitutive activity. An inverse agonist preferentially stabilizes the inactive receptor conformation, actively suppressing constitutive activity to below-baseline levels. Both block agonist-stimulated responses, but only the inverse agonist also reduces the receptor's spontaneous activity. Metoprolol's inverse agonist properties at the beta-1 receptor may contribute to its benefit in heart failure, where constitutive adrenergic receptor activity is elevated.

Correct Answer

A — The curve shifts to the right in parallel with no change in maximum response

Rationale

A competitive reversible antagonist occupies receptors and blocks agonist binding, but its binding is reversible and can be overcome by increasing agonist concentration. At sufficiently high agonist concentrations, the agonist displaces the antagonist and achieves full receptor occupancy, restoring the maximum response. This produces a parallel rightward shift of the dose-response curve — more agonist is required to produce the same effect, but the maximum effect is preserved. By contrast, an irreversible antagonist permanently removes receptors from the available pool; once receptor reserve is exhausted, the maximum response falls and cannot be restored by increasing agonist concentration.

Correct Answer

D — The tissue contains receptor reserve — downstream signal amplification saturates the response before all receptors are occupied

Rationale

Receptor reserve, also called spare receptors, describes the phenomenon in which a tissue contains more receptors than are needed to generate the maximum response. When each activated receptor triggers a highly amplified downstream signaling cascade, saturation of the effector system can occur at low receptor occupancy levels. This means the effective concentration producing half-maximum tissue response is lower than the equilibrium dissociation constant for binding — the EC50 is less than the Kd. Receptor reserve has clinical importance: an irreversible antagonist can eliminate much of the receptor pool without reducing the maximum response, until the reserve is exhausted. Low intrinsic efficacy or partial agonism would reduce the maximum response, not allow it to be reached at low occupancy.

Correct Answer

B — The maximum response is reduced and cannot be restored by increasing agonist concentration

Rationale

An irreversible antagonist permanently removes receptors from the functional pool by forming covalent bonds that cannot be reversed by agonist competition. In a tissue with no receptor reserve, every receptor is required to generate the maximum response. Permanent inactivation of 90% of receptors reduces the maximum attainable response to approximately 10% of normal. Because the antagonist cannot be displaced by agonist — its binding is irreversible — increasing agonist concentration does not restore the maximum. Recovery of the maximum response requires synthesis of new receptor protein, which takes hours to days. This insurmountable nature distinguishes irreversible from competitive reversible antagonists, whose rightward curve shifts can always be overcome by sufficient agonist.

Correct Answer

D — Buprenorphine displaces heroin from mu-opioid receptors but delivers less receptor activation per occupied receptor, reducing net opioid signaling below the level needed to suppress withdrawal

Rationale

Buprenorphine has very high affinity for the mu-opioid receptor and rapidly displaces full agonist opioids from their binding sites. As a partial agonist, it produces less downstream signaling per occupied receptor than heroin or other full agonists. In a physically dependent patient whose nervous system requires sustained full opioid signaling to prevent withdrawal, buprenorphine's takeover of receptor occupancy while delivering reduced signal precipitates withdrawal. This is why buprenorphine is typically initiated only after the patient has abstained long enough for withdrawal symptoms to begin — the drug then provides sufficient partial agonist activity to suppress, rather than precipitate, withdrawal.

Correct Answer

A — Benzodiazepines enhance gamma-aminobutyric acid-mediated channel opening only in the presence of gamma-aminobutyric acid, while barbiturates can open the channel directly without gamma-aminobutyric acid

Rationale

Benzodiazepines are positive allosteric modulators that increase the frequency of chloride channel opening when gamma-aminobutyric acid is present, but they cannot open the channel in the absence of gamma-aminobutyric acid. This gamma-aminobutyric acid dependence creates a ceiling on their central nervous system depressant effect — once all available gamma-aminobutyric acid is bound and all channels that can open are opening at maximum frequency, additional benzodiazepine produces no further response. Barbiturates at high doses can directly open the gamma-aminobutyric acid type A receptor channel without gamma-aminobutyric acid present, bypassing this ceiling and producing progressively deeper central nervous system and respiratory depression with increasing dose. This pharmacodynamic difference, not metabolic rate or affinity differences, explains the relative safety of benzodiazepines in overdose.

Correct Answer

B — Phenoxybenzamine forms an irreversible bond with alpha receptors that cannot be overcome by the massive catecholamine surges released during tumor manipulation

Rationale

Phenoxybenzamine alkylates and permanently inactivates alpha-adrenergic receptors. During pheochromocytoma surgery, manipulation of the tumor releases enormous catecholamine surges that would displace any competitive reversible alpha-blocker by simple mass action, allowing hypertensive crises to occur. Because phenoxybenzamine's blockade is irreversible, it cannot be overcome regardless of how high catecholamine concentrations rise. This insurmountable property is the specific pharmacodynamic reason for its use in preoperative preparation — it provides reliable protection against the unpredictable and extreme catecholamine releases that occur intraoperatively. Phenoxybenzamine's longer duration also reflects the need for new receptor synthesis rather than drug elimination.

Correct Answer

C — Blockade of beta-2 adrenergic receptors in bronchial smooth muscle removes sympathetic bronchodilatory tone, allowing bronchoconstriction

Rationale

Bronchial smooth muscle tone is regulated in part by sympathetic input through beta-2 adrenergic receptors, activation of which promotes relaxation and bronchodilation. In patients with asthma, this sympathetic bronchodilatory tone helps counteract the underlying tendency toward airway constriction. A non-selective beta-blocker blocks both beta-1 receptors in the heart and beta-2 receptors in the bronchi, removing this protective bronchodilatory influence and allowing unopposed bronchoconstriction. Beta-1 selective agents such as metoprolol reduce this risk but do not eliminate it at higher doses. This is why non-selective beta-blockers and even beta-1 selective agents are used with caution or avoided in patients with reactive airway disease.